PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.\', \'Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.\', \'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Statistical Analysis Division, Galilee Medical Center, Nahariya, Israel.\', \'Computer Data Division, Galilee Medical Center, Nahariya, Israel.\', \'Endocrinology Unit, Galilee Medical Center, Nahariya, Israel.\', \'Geriatric Medicine Department, Galilee Medical Center, Nahariya, Israel.\', \'Galilee Medical Center, Nahariya, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0263069
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 35113901
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all